Top

Archives of Gynecology and Obstetrics

Published in:

01-04-2010 | General Gynecology

Relationship between bone mineral density, bone turnover markers and homocysteine, folate and vitamin B12 levels in postmenopausal women

Authors: Berna Halıloglu, Fehime Benli Aksungar, Erdin Ilter, Hakan Peker, Figen Temelli Akın, Umit Ozekıcı

Published in: Archives of Gynecology and Obstetrics | Issue 4/2010

Abstract

Purpose

We aimed to investigate whether levels of homocysteine (Hcy), folate, and vitamin B12 are related to bone turnover markers and bone mineral density (BMD) in postmenopausal women.

Methods

One hundred and twenty postmenopausal women were divided into three groups: osteoporotic, osteopenic and normal, according to the BMD measurements. The age, weight, body mass index (BMI), years since menopause (YSM), gravidity, parity, bone turnover markers [type I collagen C-telopeptides (CTx) and bone-specific alkaline phosphatase (BAP)], serum Hcy, parathyroid hormone (PTH), vitamin B12, folate, calcium and magnesium levels were compared with each other.

Results

Twenty-five women had osteoporotic, 42 women had osteopenic, and 53 had normal BMD values. After adjusting for confounding factors, serum Hcy levels were significantly higher in osteoporotic women [adj OR = 38.95 (1.474–1029.88) p = 0.02]. The age, YSM, PTH, CTx and BAP levels were related to serum Hcy in all women (β = 0.523, p = 0.0001; β = 0.446, p = 0.001; β = 0.295, p = 0.005; β = 0.239, p = 0.026; β = 0.451, p = 0.001, respectively).

Conclusions

Our data showed that vitamin B12, folate and Hcy levels were not related with BMD in postmenopausal women. We think that one of the underlying mechanisms of increased Hcy levels and osteoporosis may be a mechanistic link which cannot detected by BMD or biochemical markers.

Abrahamsen B, Madsen JS, Tofteng CL, Stilgren L, Bladbjerg EM, Kristensen SR et al (2003) A common methylenetetrahydrofolate reductase (C677T) polymorphism is associated with low bone mineral density and increased fracture incidence after menopause: longitudinal data from the Danish Osteoporosis Prevention Study. J Bone Miner Res 18:723–729CrossRefPubMed

Van Meurs JB, Dhonukshe-Rutten RA, Plujim SM, van der Klift M, de Jonge R, Lindemans J et al (2004) Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med 350:2033–2041CrossRefPubMed

Herrmann M, Kraenzlin M, Pape G, Sand-Hill M, Herrmann W (2005) Relation between homocysteine and biochemical bone turnover markers and bone mineral density in peri- and postmenopausal women. Clin Chem Lab Med 43:1118–1223CrossRefPubMed

Gerdhem P, Iwaska KK, Isakkson A, Pettersson K, Vaananen HK, Obrant KJ et al (2007) Associations between homocysteine, bone turnover, BMD, mortality and fracture risk in elderly women. J Bone Miner Res 22:127–134CrossRefPubMed

Cagnacci A, Baldassari F, Rivolta G, Arangino S, Volpe A (2003) Relation of homocysteine, folate, and vitamin B12 to bone mineral density of postmenopausal women. Bone 33:956–959CrossRefPubMed

Gjesdal CG, Vollset SE, Ueland PM, Refsum H, Drevon CA, Gjessing HK et al (2006) Plasma total homocysteine level and bone mineral density: the Hordaland Homocysteine Study. Arch Intern Med 166:88–94CrossRefPubMed

Morris MS, Jacques PF, Selhub J (2005) Relation between homocysteine and B-vitamin status indicators and bone mineral density in older Americano. Bone 37:234–242CrossRefPubMed

Lubec B, Fang-Kircher S, Lubec T, Blom HJ, Boers GH (1996) Evidence for McKusick’s hypothesis of deficient collagen cross-linking in patients with homocystinuria. Biochim Biophys Acta 1315:159–162PubMed

Saito M, Fujii K, Marumo K (2006) Degree of mineralization-related collagen crosslinking in the femoral neck cancellous bone in cases of hip fracture and controls. Calcif Tissue Int 79:160–168CrossRefPubMed

10.

Krumdieck CL, Prince CW (2000) Mechanisms of homocysteine toxicity on connective tissues: implications for the morbidity of ageing. J Nutr 130:365s–368sPubMed

11.

Koh JM, Lee YS, Kim YS, Kim DJ, Kim HH, Park JY et al (2006) Homocysteine enhances bone resorption by stimulation of osteoclast formation and activity through increased intracellular ROS generation. J Bone Miner Res 21:1003–1011CrossRefPubMed

12.

Cagnacci A, Bagni B, Zini A, Cannoletta M, Generali M, Volpe A (2008) Relation of folates, vitamin B12 and homocysteine to vertebral bone mineral density change in postmenopausal women. A five-year longitudinal evaluation. Bone 42:314–320CrossRefPubMed

13.

Stone KL, Bauer DC, Sellmeyer D, Cummings SR (2004) Low serum B12 levels are associated with increased hip bone loss in older women: a prospective study. J Clin Endocrinol Metab 89:1217–1221CrossRefPubMed

14.

Delmas PD, Eastell R, Garnero P, Seibel MJ, Stepan J (2000) The use of biochemical markers of bone turnover in osteoporosis. Committee of Scientific Advisors of the International Osteoporosis Foundation. Osteoporos Int 11(Suppl 6):S2–S17

15.

Jakubowski H (2000) Homocysteine thiolactone: metabolic origin and protein homocyteinylation in humans. J Nutr 130:377S–381SPubMed

16.

Selhub J (1999) Homocysteine metabolism. Annu Rev Nutr 19:217–246CrossRefPubMed

17.

Dhonukshe-Rutten RA, Pluijm SM, de Groot LC, Lips P, Smith JH, van Staveren WA (2005) Homocysteine and vitamin B12 status relate to bone turnover markers, broadband ultrasound attenuation, and fractures in healthy elderly people. J Bone Miner Res 20:921–929CrossRefPubMed

18.

Garnero P, Sorney-Rendu E, Claustrat B, Delmas PD (2000) Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study. J Bone Miner Res 15:1526–1536CrossRefPubMed

19.

Garnero P, Sornay-Rendu E, Duboeuf F, Delmas PD (1999) Markers of bone turnover predict forearm bone loss: a 4-yr follow-up study. J Bone Miner Res 14:1614–1621CrossRefPubMed

20.

Avbersek-Luznik I, Gmeiner Stopar T, Marc J (2007) Activity or mass concentration of bone-specific alkaline phosphatase as a marker of bone formation. Clin Chem Lab Med 45:1014–1018CrossRefPubMed

21.

Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD (1996) Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J Bone Miner Res 11:337–349CrossRefPubMed

22.

Baines M, Kredan MB, Usher J, Davison A, Higgins G, Taylor W et al (2007) The association of homocysteine and its determinants MTHFR genotype, folate, vitamin B12 and vitamin B6 with bone mineral density in postmenopausal British women. Bone 40:730–736CrossRefPubMed

23.

Golbahar J, Hamidi A, Aminzadeh MA, Omrani GR (2004) Association of plasma folate, plasma total homocysteine, but not methylenetetrahydrofolate reductase C667T polymorphism, with bone mineral density in postmenopausal Iranian women: a cross-sectional study. Bone 35:760–765CrossRefPubMed

24.

Bozkurt N, Erdem M, Yılmaz E, Erdem A, Biri A, Kubatova A et al (2009) The relationship of homocysteine, B12 and folic acid with the bone mineral density of the femur and lumbar spine in Turkish postmenopausal women. Arch Gynecol Obstet 280:381–387CrossRefPubMed

25.

Herrmann M, Wildemann B, Wagner A, Wolny M, Schorr H, Taban-Shomal O et al (2009) Experimental folate and vitamin B12 deficiency does not alter bone quality in rats. J Bone Miner Res 24:589–596CrossRefPubMed

Title: Relationship between bone mineral density, bone turnover markers and homocysteine, folate and vitamin B12 levels in postmenopausal women
Authors: Berna Halıloglu
Fehime Benli Aksungar
Erdin Ilter
Hakan Peker
Figen Temelli Akın
Umit Ozekıcı
Publication date: 01-04-2010
Publisher: Springer-Verlag
Published in: Archives of Gynecology and Obstetrics / Issue 4/2010
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI: https://doi.org/10.1007/s00404-009-1297-4

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Relationship between bone mineral density, bone turnover markers and homocysteine, folate and vitamin B12 levels in postmenopausal women

Abstract

Purpose

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 4/2010

Posterior colpotomy revisited: a forgotten route for retrieving larger benign ovarian lesions following laparoscopic excision

Uterine compression sutures, an update: review of efficacy, safety and complications of B-Lynch suture and other uterine compression techniques for postpartum haemorrhage

Is it time to relinquish fundal pressure maneuver?

Ovarian tissue cryopreservation for non-malignant indications

Does residual amniotic fluid after preterm premature rupture of membranes have an effect on perinatal outcomes? 12 years experience of a tertiary care center

Costs of cervical cancer and precancerous lesions treatment in a publicly financed health care system